Insider · CIK 0001529196

Foley Mark J

Reports to the SEC for 4 companies · ALISO VIEJO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001529196

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-28	GKOSGLAUKOS Corp · Stock Option (Right to Buy)A Award	Director	AAward	+2,987 sh	—	—	2,987
2026-05-28	GKOSGLAUKOS Corp · Stock Option (Right to Buy)A Award	Director	AAward	+2,987 sh	—	—	2,987
2026-05-28	GKOSGLAUKOS CorpA Award	Director	AAward	+1,878 sh	—	—	60,267
2026-01-02	GKOSGLAUKOS CorpA Award	Director	AAward	+1,168 sh	—	—	58,389
2025-05-29	GKOSGLAUKOS Corp · Stock Option (Right to Buy)A Award	Director	AAward	+3,149 sh	—	—	3,149
2025-05-29	GKOSGLAUKOS CorpA Award	Director	AAward	+2,108 sh	—	—	57,221
2025-02-26	GKOSGLAUKOS CorpM Exercise/Conversion	Director	MExercise/Conversion	+25K sh	$32.00	+$800K	59,936
2025-02-26	GKOSGLAUKOS CorpS Sale	Director	SSale	−20.7K sh	$120.72	−$2.5M	54,249
2025-02-26	GKOSGLAUKOS CorpM Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$24.69	+$370K	74,936
2025-02-26	GKOSGLAUKOS Corp · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0
2025-02-26	GKOSGLAUKOS Corp · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−25K sh	—	—	0
2025-02-06	Revance Therapeutics, Inc.D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−84.7K sh	—	—	0
2025-02-06	Revance Therapeutics, Inc.A Award	Director, President & CEO	AAward	+84.7K sh	—	—	84,686
2025-02-06	Revance Therapeutics, Inc.D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−27.9K sh	—	—	0
2025-02-04	Revance Therapeutics, Inc.U Disposition from Tender	Director, President & CEO	UDisposition from Tender	−997K sh	$3.65	−$3.64M	27,933
2025-02-04	Revance Therapeutics, Inc.U Disposition from Tender	Director, President & CEO	UDisposition from Tender	−111K sh	$3.65	−$405K	0
2025-02-03	Revance Therapeutics, Inc.A Award	Director, President & CEO	AAward	+27.9K sh	—	—	1,024,868
2025-01-02	GKOSGLAUKOS CorpA Award	Director	AAward	+864 sh	—	—	35,800
2024-12-31	Revance Therapeutics, Inc.A Award	Director, President & CEO	AAward	+1,000 sh	$2.18	+$2,184.5	996,935
2024-06-30	Revance Therapeutics, Inc.A Award	Director, President & CEO	AAward	+1,000 sh	$2.18	+$2,184.5	995,935
2024-05-30	GKOSGLAUKOS Corp · Stock Option (Right to Buy)A Award	Director	AAward	+1,246 sh	—	—	1,246
2024-05-30	GKOSGLAUKOS CorpA Award	Director	AAward	+1,716 sh	—	—	34,936
2024-03-15	Revance Therapeutics, Inc.F Tax Payment	Director, President & CEO	FTax Payment	−17.2K sh	$5.30	−$91.4K	994,935
2024-03-15	Revance Therapeutics, Inc.F Tax Payment	Director, President & CEO	FTax Payment	−3,305 sh	$5.30	−$17.5K	1,012,163
2024-03-06	Revance Therapeutics, Inc.P Purchase	Director, President & CEO	PPurchase	+30K sh	$6.98	+$209K	1,015,468
2024-02-29	Revance Therapeutics, Inc.A Award	Director, President & CEO	AAward	+70.8K sh	—	—	985,468
2024-02-23	GKOSGLAUKOS CorpS Sale	Director	SSale	−4,560 sh	$92.87	−$423K	33,220
2024-02-23	GKOSGLAUKOS CorpM Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$7.28	+$72.8K	37,780
2024-02-23	GKOSGLAUKOS Corp · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2024-01-31	Revance Therapeutics, Inc.Performance Stock UnitsA Award	Director, President & CEO	AAward	+1.07M sh	—	—	1,070,001
2023-12-31	Revance Therapeutics, Inc.A Award	Director, President & CEO	AAward	+264 sh	$7.47	+$1,972.08	914,718
2023-08-11	Revance Therapeutics, Inc.F Tax Payment	Director, President & CEO	FTax Payment	−48.1K sh	$18.91	−$909K	914,454
2023-08-11	Revance Therapeutics, Inc.A Award	Director, President & CEO	AAward	+122K sh	—	—	962,518
2023-08-03	Revance Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−26.3K sh	$22.57	−$593K	840,375
2023-07-03	Revance Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−26.3K sh	$24.94	−$655K	866,654
2023-06-30	Revance Therapeutics, Inc.A Award	Director, President & CEO	AAward	+1,000 sh	$15.61	+$15.6K	892,933
2023-06-09	Revance Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−31.3K sh	$30.72	−$961K	891,933
2023-06-01	GKOSGLAUKOS CorpA Award	Director	AAward	+3,230 sh	—	—	27,780
2023-05-15	Revance Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−70.4K sh	$34.55	−$2.43M	923,212
2023-03-15	Revance Therapeutics, Inc.F Tax Payment	Director, President & CEO	FTax Payment	−5,341 sh	$30.65	−$164K	818,010
2023-03-09	Revance Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−70.4K sh	$31.59	−$2.22M	823,351
2023-01-03	GKOSGLAUKOS CorpA Award	Director	AAward	+2,948 sh	—	—	24,550
2022-12-31	Revance Therapeutics, Inc.A Award	Director, President & CEO	AAward	+605 sh	$12.18	+$7,369.203	718,092
2022-10-13	Revance Therapeutics, Inc.F Tax Payment	Director, President & CEO	FTax Payment	−49.3K sh	$26.97	−$1.33M	717,487
2022-09-22	Revance Therapeutics, Inc.A Award	Director, President & CEO	AAward	+176K sh	—	—	893,741
2022-06-30	Revance Therapeutics, Inc.A Award	Director, President & CEO	AAward	+1,000 sh	$11.75	+$11.7K	766,761
2022-06-02	GKOSGLAUKOS CorpA Award	Director	AAward	+4,364 sh	—	—	21,602
2022-03-15	Revance Therapeutics, Inc.F Tax Payment	Director, President & CEO	FTax Payment	−3,304 sh	$15.79	−$52.2K	765,761
2022-02-02	Revance Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+143K sh	—	—	143,354
2022-02-02	Revance Therapeutics, Inc.A Award	Director, President & CEO	AAward	+176K sh	—	—	993,659

Recent filings

Accepted (ET)
Jun 234/A
Foley Mark J0001529196-26-000006
SEC(opens sec.gov)
Jun 14
Foley Mark J0001529196-26-000004
SEC(opens sec.gov)
Jan 74
Foley Mark J0001529196-26-000002
SEC(opens sec.gov)
Jun 24
Foley Mark J0001415889-25-015178
SEC(opens sec.gov)
Feb 284
Foley Mark J0001415889-25-006046
SEC(opens sec.gov)
Feb 64
Foley Mark J0000950170-25-015363
SEC(opens sec.gov)
Feb 54
Foley Mark J0000950170-25-014825
SEC(opens sec.gov)
Jan 34
Foley Mark J0001479290-25-000004
SEC(opens sec.gov)
Jul 24
Foley Mark J0001479290-24-000104
SEC(opens sec.gov)

Companies

Address

C/O GLAUKOS CORPORATION ONE GLAUKOS WAY

ALISO VIEJO, CA, 92656